0001891885-22-000001.txt : 20221220
0001891885-22-000001.hdr.sgml : 20221220
20221220074809
ACCESSION NUMBER: 0001891885-22-000001
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(1)
ITEM INFORMATION: Section 3(c)(7)
FILED AS OF DATE: 20221220
DATE AS OF CHANGE: 20221220
EFFECTIVENESS DATE: 20221220
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BioTrack Capital Fund II, LP
CENTRAL INDEX KEY: 0001891885
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-425894
FILM NUMBER: 221472844
BUSINESS ADDRESS:
STREET 1: 2ND FLOOR, HARBOUR PLACE
STREET 2: 103 SOUTH CHURCH STREET, PO BOX 472
CITY: GEORGE TOWN, GRAND CAYMAN
STATE: E9
ZIP: KY1-1106
BUSINESS PHONE: 85228016066
MAIL ADDRESS:
STREET 1: 2ND FLOOR, HARBOUR PLACE
STREET 2: 103 SOUTH CHURCH STREET, PO BOX 472
CITY: GEORGE TOWN, GRAND CAYMAN
STATE: E9
ZIP: KY1-1106
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001891885
BioTrack Capital Fund II, LP
2ND FLOOR, HARBOUR PLACE
103 SOUTH CHURCH STREET, PO BOX 472
GEORGE TOWN, GRAND CAYMAN
E9
CAYMAN ISLANDS
KY1-1106
85228016066
CAYMAN ISLANDS
None
None
Limited Partnership
true
2021
Zhongji
Zhi
2nd Floor, Harbour Place
103 South Church Street, PO Box 472
Grand Cayman
E9
CAYMAN ISLANDS
KY1-1106
Director
Director of General Partner of Issuer
Penghui
Chen
2nd Floor, Harbour Place
103 South Church Street, PO Box 472
Grand Cayman
E9
CAYMAN ISLANDS
KY1-1106
Director
Director of the General Partner of the Issuer
Pooled Investment Fund
Venture Capital Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.1
- 3C.7
true
0001891885-21-000001
2021-12-22
true
true
true
false
0
FirstPoint Equity Capital Ltd
None
Crito Capital LLC
161724
8 Wright Street
Westport
CT
CONNECTICUT
06880
true
Indefinite
202000000
Indefinite
false
50
0
true
0
true
0
true
The general partner (or its affiliates) is entitled to a performance allocation and a management fee. The performance allocation and management fee are fully discussed in the Issuer's confidential offering materials.
false
BioTrack Capital Fund II, LP
Chen Penghui
Chen Penghui
Director of General Partner of Issuer
2022-12-20